FIELD: medicine.
SUBSTANCE: group of inventions exhibits a therapeutic effect on solid and hematological tumors. Derivatives of the compound of formula (IV) are provided. In another embodiment, the use of the said compounds in the manufacture of a DNA-RK inhibitor is provided.
EFFECT: group of inventions provides new derivatives of compounds of formula (IV) having inhibitory activity against DNA-RK.
14 cl, 1 dwg, 8 tbl, 31 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRIDOPYRIMIDINE COMPOUNDS ACTING AS DOUBLE INHIBITORS OF mTORC 1/2 | 2018 |
|
RU2771201C2 |
| RESORCINOL DERIVATIVE AS HSP90 INHIBITOR | 2016 |
|
RU2697703C2 |
| QUINOLINE DERIVATIVES AS SMO INHIBITORS | 2015 |
|
RU2695815C2 |
| THIENODIAZEPINE DERIVATIVES AND THEIR USE | 2018 |
|
RU2795005C2 |
| PDE4 INHIBITOR | 2017 |
|
RU2743126C2 |
| MACROCYCLIC COMPOUND WITH FUNCTIONS OF WEE1 INHIBITOR AND ITS APPLICATION OPTIONS | 2018 |
|
RU2783243C2 |
| 2,3-DIHYDRO-1H-PYRROLISINE-7-FORMAMIDE DERIVATIVE AND ITS APPLICATIONS | 2019 |
|
RU2792726C2 |
| DERIVATIVE WITH CONDENSED RING AS A RECEPTOR INHIBITOR | 2018 |
|
RU2748993C1 |
| THIAZOLACTAM COMPOUNDS AS ERK INHIBITORS AND THEIR APPLICATIONS | 2020 |
|
RU2805569C1 |
| SPIRO COMPOUNDS AS ERK INHIBITORS AND THEIR USE | 2020 |
|
RU2800042C1 |
